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Abstract The aim of this study was to summarize all
eligible studies to compare the effectiveness of treatment
strategies for osteochondral defects (OCD) of the talus.
Electronic databases from January 1966 to December 2006
were systematically screened. The proportion of the patient
population treated successfully was noted, and percentages
were calculated. For each treatment strategy, study size
weighted success rates were calculated. Fifty-two studies
described the results of 65 treatment groups of treatment
strategies for OCD of the talus. One randomized clinical
trial was identiﬁed. Seven studies described the results of
non-operative treatment, 4 of excision, 13 of excision and
curettage, 18 of excision, curettage and bone marrow
stimulation (BMS), 4 of an autogenous bone graft, 2 of
transmalleolar drilling (TMD), 9 of osteochondral trans-
plantation (OATS), 4 of autologous chondrocyte implan-
tation (ACI), 3 of retrograde drilling and 1 of ﬁxation.
OATS, BMS and ACI scored success rates of 87, 85 and
76%, respectively. Retrograde drilling and ﬁxation scored
88 and 89%, respectively. Together with the newer tech-
niques OATS and ACI, BMS was identiﬁed as an effective
treatment strategy for OCD of the talus. Because of the
relatively high cost of ACI and the knee morbidity seen in
OATS, we conclude that BMS is the treatment of choice
for primary osteochondral talar lesions. However, due to
great diversity in the articles and variability in treatment
results, no deﬁnitive conclusions can be drawn. Further
sufﬁciently powered, randomized clinical trials with uni-
form methodology and validated outcome measures should
be initiated to compare the outcome of surgical strategies
for OCD of the talus.
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Introduction
Symptomatic osteochondral ankle defects often require
surgical treatment. An osteochondral ankle defect is a lesion
of the talar cartilage and subchondral bone mostly caused
by a single or multiple traumatic events, leading to partial or
complete detachment of the fragment. The defects cause
deep ankle pain associated with weightbearing. Impaired
function, limited range of motion, stiffness, catching,
locking and swelling may be present. These symptoms
place the ability to walk, work and perform sports at risk.
The injury was classiﬁed by Berndt and Harty in 1959
[6]. Anatomic studies on cadaver limbs demonstrated the
etiological mechanism of transchondral fractures of the
lateral border of the talar dome. As the foot is inverted on
the leg, the lateral border is compressed against the face of
the ﬁbula (stage I), while the collateral ligament remains
intact. Further inversion ruptures the lateral ligament and
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DOI 10.1007/s00167-009-0942-6begins avulsion of the chip (stage II), which may be
completely detached but remain in place (stage III) or be
displaced by inversion (stage IV). Berndt and Harty
experimentally proved the traumatic etiology of the lesion;
however, non-traumatic lesions also occur.
Treatmentstrategiesforosteochondraldefects(OCDs)of
the ankle have substantially increased over the last decade.
The widely published treatment strategies of symptomatic
osteochondral lesions include the non-surgical treatment
with rest or cast immobilization, and surgical excision of the
lesion, excision and curettage, excision combined with
curettage and drilling/microfracturing (i.e., bone marrow
stimulation,BMS),placementofanautogenous(cancellous)
bone graft, antegrade (transmalleolar) drilling (TMD), ret-
rograde drilling, ﬁxation and newer techniques like osteo-
chondral transplantation (osteochondral autograft transfer
system, OATS) and autologous chondrocyte implantation
(ACI). The last two techniques focus at replacement and
regeneration of hyaline cartilage, respectively.
The goal of these treatment strategies is to diminish
symptoms like pain and swelling, and to improve function.
Publications on the effectiveness of these treatment strat-
egies vary. In most cases, several treatment options are
viable, and the choice of treatment is based on the type and
size of the defect and on preferences of the treating
clinician.
The last systematic review concerning treatment strate-
gies for OCDs of the talar dome was an update of a pre-
vious review [57] and included studies up to June 2000
[61]. However, since this date many studies concerning the
newer techniques ACI [4, 16, 40, 63] and OATS have been
published [1, 15, 17, 20, 28, 31, 47, 49, 50]. The aim of this
study is to provide an up to date overview by pooling those
studies dealing with treatment strategies for osteochondral
ankle defects in order to summarize the effectiveness of
these strategies.
Patients and methods
Electronic databases MEDLINE, EMBASE, CENTRAL
and DARE (January 1966–December 2006) were screened.
As main key words ‘Therapy; Treat*; Talus; Talar; Ankle;
Cartilage*; Osteochondritis Dissecans; Chondral; Osteo-
chondral and Transchondral were used. The search strategy
for MEDLINE was as follows: (therapy or treat$) and (talar
or talus or ankle) and (cartilag$ or osteochondritis dissec-
ans or talar or chondral or osteochondral or transchondral).
No language limitations were imposed. The reference lists
of all the articles selected were screened for additional
articles.
All RCTs or quasi-experimental research that evaluated
the effectiveness of treatment strategies for osteochondral
lesions of the talus were included. This included case
series. Published studies describing the results of the fol-
lowing treatment strategies were included: non-operative
treatment—rest, non-operative treatment—cast, excision of
the fragment, excision and curettage, excision and curet-
tage and drilling/microfracturing, placement of a cancel-
lous bone graft, antegrade (transmalleolar) drilling, OATS,
ACI, retrograde drilling and ﬁxation of the lesion. Studies/
patients were excluded if: a combination of diagnoses was
evaluated, and results were not separately described for the
osteochondral talar lesion group, follow-up was less than
6 months, therapy was inadequately described, patients
were under 18 years old, less than 10 patients were inclu-
ded (excluding single case reports), the study was the lesser
extensive of a double publication, there was no well-
deﬁned outcome and if there was a combination of thera-
pies described, and results were not described per therapy.
Two reviewers (MZ and DO) independently assessed the
articles for inclusion. Forms speciﬁcally developed for and
tailored to this review were used. Agreement was needed
for inclusion. In case of disagreement, the opinion of a
third independent investigator (CvD) was decisive. To
prevent investigator bias, scoring of the manuscript was
blinded to author and institute.
Successful treatment was deﬁned as an excellent or good
result at follow-up, deﬁned by an accepted scoring system,
like the AOFAS Ankle/Hindfoot scale [24], the Hannover
Scoring System [54] and others (see Table 2). If the suc-
cess rate was not deﬁned by the author, the results were
integrated into the widely accepted scoring system of
Thompson and Loomer [56]. The proportion of the patient
population treated successfully was noted, and percentages
were calculated. For each treatment strategy, study size
weighted success rates were calculated (for each treatment
category: sum of the successfully treated patients divided
by the total number of treated patients within that
category).
The primary outcomes were the effects of treatment on
symptoms, measured by scoring systems concerning the
ankle (mainly the AOFAS Ankle/Hindfoot scale).
The Newcastle-Ottawa Scale (NOS) [62], adjusted for
case series, was used for quality assessment of the included
studies. It was originally developed as an instrument to
provide an easy and convenient tool for quality assessment
of nonrandomized studies, i.e., case–control and cohort
studies, to be used in a systematic review. The Newcastle-
Ottawa Scale uses a ‘‘star’’ rating system to judge quality
based on three aspects of the study: selection of study
groups, comparability of study groups and ascertainment of
either the exposure or outcome of interest (dependent on
assessment of case–control or cohort study, respectively).
The maximum number of stars a study may receive in each
of these three categories is 4, 1 and 3, respectively, for a
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123total of 8 possible stars. The validity of the scale has been
previously established. In orthopedic literature, the vast
majority of publications involve case series. We adjusted
the NOS for case series to perform a quality assessment of
the included case series. Studies were scored for study
design, selection and assessment of outcome. The maxi-
mum numbers of stars a study could receive in the NOS
adjusted for case series was 2, 1 and 2, respectively, for a
total of 5 possible stars (Appendix 1).
Results
Description of studies
The search strategy identiﬁed over 2,000 articles. A total of
183 publications describing the results of treatment of talar
osteochondral lesions could be identiﬁed. One randomized
clinical trial was found [17]. Therefore, the conventional
measures of summarizing estimates of effectiveness could
not be used. We used pooling of the estimates of the out-
come in individual studies.
Hundred and thirty-one studies were excluded due to
one or more exclusion criteria, being: combination of
diagnoses (n = 14), inappropriate duration of follow-up
(n = 14), improper description of therapy (n = 8), age
under 18 years (n = 17), case report (n = 33), double
publication (n = 17), non-interpretable results (n = 37),
less than 10 patients (n = 37) and a combination of ther-
apies (n = 25) (Table 1). This left 52 studies describing
the results of 65 treatment groups. Three described the
results of non-operative treatment—rest, 4 of non-operative
treatment—cast, 4 of excision, 13 of excision and curet-
tage, 18 of excision and curettage and BMS, 3 of retrograde
drilling, 4 of ACI, 9 of OATS, 1 of ﬁxation with bone pegs,
4 of cancellous bone grafting and 2 of antegrade (trans-
malleolar) drilling.
Population characteristics
The total number of included patients with osteochondral
talar lesions in the 52 studies was 1361. The average age
was 31 years [18–75], 63% were male and 37% female.
The right ankle was involved in 57%, the left in 43%.
Lesions were medial in 62%, lateral in 36%, central in 1%
and medial and lateral in 1%. A history of ankle trauma
was reported in 86% of cases. There was a primary defect
in 84%. For about half of the patients, the Berndt and Harty
stage was mentioned. In 13%, it considered a Berndt and
Harty stage 1 lesion, in 22% a stage 2 lesion, in 40% a
stage 3 lesion and in 25% a stage 4 lesion. The AOFAS
Ankle/Hindfoot scale was most used [24] (Table 2).
Treatment strategies
Non-operative treatment: rest
This may be rest and/or restriction of (sporting) activities
with or without treatment of non-steroidal anti-inﬂamma-
tory drugs (NSAIDs). The aim is to unload the damaged
cartilage, so edema can resolve and necrosis is prevented.
Another objective could be healing of a (partly) detached
fragment to the surrounding bone. Three studies, 86
patients in total, described the results of rest for OCD [7,
45, 51]. Reasons to choose for non-operative treatment
were not always clearly described. Two studies date from
Table 1 Criteria that were used
Exclusion criteria No.
Combination of diagnoses 14
Follow-up\6 months 14
Therapy inadequately described 8
\18 Years old 17
Single case report 33
Double publication 17
No well-deﬁned outcome 37
\10 Patients 37
Combination of therapies 25
Total no. of excluded studies 202
Table 2 Scoring systems used for treatment of talar osteochondral
lesions in the included studies
Scoring system No. of studies
AOFAS Ankle/Hindfoot scale 16
Scoring system developed by the authors 18
Hannover score 5
Patient satisfaction score 5
Criteria proposed by Berndt and Harty 5
Visual analog scale 3
Martin score 3
Alexander and Lichtman 3
Ogilvie Harris score 2
MODEMS 2
Karlsson scoring scale 2
Tegner score 1
Evaluation proposed by Loomer 1
Mazur score 1
Freiburg ankle score 1
SANE 1
According to Thompson and Loomer 1
McCullough score 1
Some studies used more than one scoring system
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123the past (1953 [45] and 1975 [7]), when surgical treatment
of osteochondral talar lesions was not as common as it is
today. In the majority of studies, the duration of symptoms
prior to institution of non-operative treatment was either
unreported or ranged from sub-acute to acute (\6 weeks)
to chronic ([6 weeks). In the most recent study, patients
were given the choice between operative and non-operative
treatments, and the patient chose non-operative treatment.
Conservative treatment consisted of weightbearing as tol-
erated [51]. In 39 of 86 patients (45%), conservative
treatment reported to be successful (range 20–54%).
Non-operative treatment: cast
The aim is similar to the treatment option described pre-
viously, but then pursued by cast immobilization for at
least 3 weeks up to 4 months. Four studies reported the
results of this treatment [7, 10, 22, 41]. All date back at
least two decades. The main reason to decide for cast
immobilization was a Berndt and Harty stage II or III
lesion. In 44 of the 83 patients (53%), the treatment was
reported to be successful (range 29–69%).
Excision
The partially detached fragment is excised, and the defect
itself is left untreated. The results were reported in four
studies [12, 23, 37, 41]. In two studies, excision was per-
formed for superﬁcial cartilaginous lesions, with mainly
intact underlying subchondral bone. Sometimes it involved
a loose intra-articular fragment. In one study, the lesions
involved bony necrosis underneath. In 32 of 59 patients,
the result was reported to be successful (54%). Success
rates varied from 30 to 88%.
Excision and curettage
After excision of the loose body, the surrounding necrotic
subchondral tissue is curetted using either an open or
arthroscopic technique. Most patients had a Berndt and
Harty stage III or IV lesion, although also stage II lesions
occurred. Thirteen studies, a total of 259 patients, reported
the results of OCD treatment by excision and curettage [7,
10, 12, 17, 22, 23, 32, 33, 35, 38, 39, 42, 44]. In 199 of 259
patients, a successful result was reported (77%). The suc-
cess rate varied from 56 to 94%.
Excision, curettage and BMS
Following excision and curettage (debridement), multiple
connections with the subchondral bone are created. This can
be accomplished by drilling or microfracturing. The objec-
tiveistopartiallydestroythecalciﬁedzonethatismostoften
present and to create multiple openings into the subchondral
bone. Intra-osseous blood vessels are disrupted, and the
release of growth factors leads to the formation of a ﬁbrin
clot. The formation of local new blood vessels is stimulated,
bone marrow cells are introduced in the osteochondral
defect, and ﬁbro-cartilaginous tissue is formed. Patients
often had a Berndt and Harty stage III or IV lesion, although
stage I and II lesions occurred. Diameter of the lesions usu-
ally did not exceed 1.5 cm. A total of 18 studies, including
388 patients, described the results of BMS [2, 3, 5, 8, 11, 13,
14, 17–19, 21, 34, 36, 37, 48, 52, 55, 60]. In 329 of 386
patients, treatment was reported to be successful (85%). The
success rate varied from 46 to 100%.
Excision, curettage and autogenous bone graft
In this technique, the defect that remains after excision, and
curettage is ﬁlled with autogenous cancellous bone. The
aim is to restore the weightbearing properties of the talus.
Indications for treatment were large, often medial lesions,
exceeding 1.5 cm in diameter. Four publications reported
the results of this technique for 74 patients [9, 13, 25, 27].
In 45 of 74 patients, the result was successful. Success rates
varied from 41 to 93%.
Antegrade (transmalleolar) drilling
In case an osteochondral lesion is hard to reach because of
its location on the talar dome, the defect can be drilled
through the malleolus. A K-wire is inserted about 3 cm
proximal to the tip of the medial malleolus and directed
across the medial malleolus into the lesion through the
intact cartilage. Two publications described the results of
this technique for 41 patients [26, 44]. In 26 patients, the
result was reported to be successful (63%, range 32–100%).
Osteochondral transplantation/OATS
Osteochondral autografts have been introduced as an alter-
native to allografts for the treatment of OCDs. Two related
procedures have been developed: mosaicplasty and OATS.
Botharereconstructivebonegraftingtechniquesthatuseone
or more cylindrical osteochondral grafts from the less
weightbearing periphery of the ipsilateral knee and trans-
plantthemintotheprepareddefectsiteonthetalus.Itsgoalis
to reproduce the mechanical, structural and biochemical
properties of the original hyaline articular cartilage which
has become damaged. It is carried out either by an open
approach or by an arthroscopic procedure. Indications
involve large, often medial lesions, sometimes with a cyst
underneath. In some cases, it involves secondary treatment,
after failed primary (surgical) treatment. Nine publications
describedtheresultsof243patientstreatedbyosteochondral
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123transplantation [1, 15, 17, 20, 28, 31, 47, 49, 50]. Good/
excellent results were obtained in 212 patients (87%). Suc-
cess rates varied from 74 to 100%. Morbidity of the donor
knee joint was seen in 12% of patients (0–37%). Three
studies did not discuss the possibility of post-operative knee
pain [20, 28, 47].
Autologous chondrocyte implantation/ACI
Autologous chondrocyte implantation attempts to regener-
atetissuewithahighpercentageofhyaline-likecartilage.By
means of an arthroscopic approach, a region of healthy
articular cartilage is identiﬁed, and a biopsy is taken. The
tissue is minced and enzymatically digested. Chondrocytes
are separated by ﬁltration, and the isolated chondrocytes are
cultivatedinculturemediumfor11–21 days.Anarthrotomy
is performed, and the chondral lesion is excised up to the
healthy surrounding cartilage. A periosteal ﬂap is removed
fromthetibiaandissuturedtothesurroundingrimofnormal
cartilage. The cultured chondrocytes are then injected
beneath the periosteal ﬂap. It is done for lesions larger than
1c m
2, in the absence of generalized osteoarthritic changes.
Four studies, describing 59 patients, were included [4, 16,
40, 63]. In 45 of 59 patients (76%), a successful result was
reported. The success rate varied from 70 to 92%.
Retrograde drilling
Retrograde drilling is done for primary OCDs when there is
more or less intact cartilage with a large subchondral cyst,
or when the defect is hard to reach via the usual
anterolateral and anteromedial portals. For medial lesions,
arthroscopic drilling can take place through the sinus tarsi.
For lateral lesions the cyst is approached from anterome-
dial. The aim is to induce subchondral bone revasculari-
zation and subsequently to stimulate the formation of new
bone. A cancellous graft may be placed to ﬁll the gap.
Three studies, comprising 42 patients, were included [26,
46, 53]. It mainly involved medial lesions. Size of the
lesions was not described. Post-operatively immediate
range-of-motion exercises were commenced in all studies.
Partial weightbearing was started 2, 4 or 6 weeks post-
operatively [26, 46, 53]. In 37 of 42 patients, the treatment
was reported to be successful (88%, range 81–100%).
Fixation
In case of a large loose fragment, one can choose to secure
it to the underlying bone using either a screw, pin, rod or
ﬁbrin glue. One publication, for a total of 27 patients, met
our inclusion criteria [29]. In this study, stage II–IV lesions
were elevated, the bed was curetted and drilled, and after
alignment of the fragment it was reattached with at least
two bone pegs from the distal tibia. Results were reported
to be successful in 24 patients (89%).
Results are summarized in Table 3.
Quality assessment of included studies
On ‘study design’, together 52 studies scored a total of 28
stars, out of a possible 104. Seven studies were prospective
in design; however, most case series were retrospectively
Table 3 Results per treatment strategy
Treatment strategy No. of studies No. of patients No. of patients
good/excellent result
Study weighted
success rate (%)
Range (%)
Non-operative, rest 3 86 39 45 20–54
Non-operative, cast 4 83 44 53 29–69
Excision 4 59 32 54 30–88
Excision and curettage 13 259 199 77 56–94
Excision, curettage and BMS 18 388 329 85 46–100
Autogenous bone graft 4 74 45 61 41–93
TMD 2 41 26 63 32–100
OATS 9 243 212 87 74–100
ACI 4 59 45 76 70–92
Retrograde drilling 3 42 37 88 81–100
Fixation, bone pegs 1 27 24 89 –
Described are the number of included studies per treatment strategy as mentioned in the ﬁrst column, the cumulative number of patients per
treatment strategy, the number of patients with a good or excellent result at follow-up, the success percentage per treatment strategy and ﬁnally
the range of the success percentages
BMS bone marrow stimulation, ACI autologous chondrocyte implantation, OATS osteochondral autograft transfer system, TMD transmalleolar
drilling
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123executed [36], and in 9 studies, the pro- or retrospective
nature of the study was not described. Twenty-one studies
accounted for the protocol they had followed, but the
majority of studies did not mention a protocol, or did not
describe it properly. On ‘selection,’ 48 out of 52 possible
stars were scored. Nearly all studies reported on a repre-
sentative patient group. On ‘outcome’ 34 out of 104 stars
were scored. In none of the studies, blind assessment was
described (often it was not clear whether patients were
scored by someone else than the author), and loss to follow
up exceeded 5% in many cases.
Discussion
The most important ﬁnding of the present study was that
bone marrow stimulation (BMS) was identiﬁed as the best
treatment option.
The review summarizes 65 study groups in 52 studies
that describe treatment strategies for osteochondral talar
lesions. There was a great diversity in trials concerning
patient characteristics, staging of the defect, duration of
follow-up and outcome measures. A relatively large number
of studies were dedicated to treatment by excision and
curettage, excision and curettage and BMS, and OATS. The
number of patients in other categories, mainly retrograde
drilling, ﬁxation and transmalleolar drilling (TMD), was too
limited for a reliable interpretation of the results. Therefore,
no deﬁnitive conclusions can be drawn. Recommendations
concerning these techniques must be judged in this light.
Retrograde drilling is usually reserved for large OCDs with
intact overlying cartilage, as conﬁrmed by arthroscopy. It is
the treatment of choice when there is a large subchondral
cyst with overlying healthy cartilage. However, sizes of the
lesions were not described in any of the studies concerning
retrograde drilling [26, 46, 53]. Fixation is indicated for
lesions in which a large fragment can be reattached. It is
applied especially in (sub)acute cases and in adolescents
and children. Transmalleolar drilling is performed when a
defect is hard to reach because of its location on the talar
surface. A disadvantage is that healthy tibial cartilage is
damaged. The reported results do not support the use of this
technique [26, 44]. Besides, most talar lesions can be
reached by means of the standard anterior or posterior
arthroscopic approach, using intermittent distraction and a
90 microfracture probe [58, 59, 64].
The results of non-operative treatment were low com-
pared to operative treatment. In spite of this, non-operative
treatment should always be the ﬁrst treatment to be
considered.
Today, most publications on treatment of osteochondral
lesions of the talus involve arthroscopic excision, curettage
and bone marrow stimulation, ACI and OATS. They scored
success percentages of 85, 76 and 87, respectively. ACI is a
relatively expensive technique, and OATS gives morbidity
from knee complaints in a relevant number of patients—up
to 36% in literature [1, 15, 30, 43]. Therefore, we recom-
mend arthroscopic excision, curettage and BMS to be the
ﬁrst treatment of choice for primary osteochondral talar
lesions. It is relatively inexpensive, there is low morbidity,
a quick recovery and a high success rate.
The results of this review differ slightly from the results
described in the review of Verhagen et al. [61]. Results of
both reviews are listed in Table 4. The success percentage
for BMS has changed very little. Verhagen included 21
studies and 227 patients, and this review included 18 studies
and 388 patients. The success rate went from 86 to 85%. For
OATS, the success rate changed from 94 to 87%. Verhagen
found one study with 36 patients treated with this technique.
We identiﬁed nine eligible studies comprising 243 patients.
Table 4 Success percentages
(patients with a good/excellent
result at follow-up after
treatment of an osteochondral
talar lesion) of a previous
review by Verhagen et al. [61]
compared to the current review
Treatment strategy Verhagen et al. studies
published up to 2000 (%)
Current review, studies
published up to 2006 (%)
Non-operative treatment—rest 45 45
Non-operative treatment—cast – 53
Excision 38 54
Excision and curettage 76 77
Excision, curettage and BMS 86 85
Autogenous bone graft 85 61
TMD – 63
OATS 94 87
ACI – 76
Retrograde drilling 81 88
Fixation 73 89
Total 76
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123In the previous review, the ACI technique was not inclu-
ded. We now identiﬁed four studies, comprising 59
patients, describing the results of ACI, leading to a success
percentage of 76%. Our exclusion criteria were stricter
than those of the previous review. Considering the number
of patients, Verhagen et al. excluded single case reports,
but included series of two patients and more. To be
included in our review, each study group had to involve 10
patients or more. This excluded the ‘extended case reports’
and only allowed true case series to be evaluated. Our
initial goal was to only include study groups of 20 patients
or more. This protocol, however, excluded too many
studies, and we stretched our criteria to 10 patients. In
comparison with Tol [57], this eliminated 13 studies (and
18 treatment groups) and in comparison with Verhagen
[61] it is 30 studies.
For the quality of the review, we would have preferred
to include only the highest level of evidence, which are
randomized clinical trials. However, only one RCT was
identiﬁed, describing the results of chondroplasty (excision
and curettage), microfracturing and osteochondral trans-
plantation [17]. Looking at the set-up and inclusion of this
study one, can debate whether this study was a truly ran-
domized trial, as is also stated by the authors of the article.
We identiﬁed no case control studies.
Assessment of quality by the adjusted NOS showed that
studies scored low on study design. Studies scored mod-
erately concerning ‘outcome’, since no study described
whether blind assessment was part of the protocol, and in
many studies there was a loss to follow up exceeding 5%.
The NOS adjusted for case series, as used in this study, has
not been validated. However, scoring low on the items
described earlier leads to a higher chance of introducing
bias.
The clinical relevance of the present study is the iden-
tiﬁcation of the most effective treatment options for pri-
mary osteochondral lesions of the talus, which can serve as
a guideline for treatment in clinical practice.
Conclusion
Based on the current best available evidence, at present,
treatment by means of debridement and bone marrow
stimulation is the most effective treatment strategy for
symptomatic osteochondral lesions of the talus. To draw
deﬁnitive conclusions, sufﬁciently powered, randomized
clinical trials with uniform methodology and validated
outcome measures should be initiated.
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Appendix 1: Newcastle: Ottawa quality assessment
scale
Adjusted for case series
Study design
1. Type of study
a. Prospective*
b. Retrospective
c. Other
d. Not described
2. Set-up
a. According to protocol*
b. Without protocol
c. No protocol described
Selection
3. Representativeness of included patients
a. Truly representative of the average talar OCD
patient in the community*
b. Somewhat representative of the average talar OCD
patient in the community*
c. Selected group of patients by surgeon
d. No description of the derivation of the patient
group
Outcome
4. Assessment of outcome
a. Independent blind assessment*
b. Record linkage*
c. Self-report
d. No description
5. Adequacy of follow-up of series
a. Complete follow-up—all subjects accounted for*
b. Subjects lost to follow-up unlikely to introduce
bias—small number lost (\5%)*
c. Follow-up rate\95% and no description of those
lost
d. No statement
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123Number of assigned stars
Study design Selection Outcome
Every included study was separately assessed for quality using an
adjusted version of the Newcastle Ottawa Scale, as described earlier.
It was performed by scoring each study for study design (0–2 stars),
selection of patients (0–1 star) and outcome (0–2 stars). The designs
that earned a star are marked with a *. For each study, the total
number of stars was noted in the box given
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